Measuring  ||| S:0 E:10 ||| VBG
the  ||| S:10 E:14 ||| DT
efficacy  ||| S:14 E:23 ||| NN
of  ||| S:23 E:26 ||| IN
antimicrobial  ||| S:26 E:40 ||| FW
catheters  ||| S:40 E:50 ||| FW
Catheter-associated  ||| S:50 E:70 ||| FW
urinary  ||| S:70 E:78 ||| FW
tract  ||| S:78 E:84 ||| FW
infections  ||| S:84 E:95 ||| FW
( ||| S:95 E:96 ||| -LRB-
CAUTI ||| S:96 E:101 ||| NNP
)  ||| S:101 E:103 ||| -RRB-
are  ||| S:103 E:107 ||| VBP
a  ||| S:107 E:109 ||| DT
major  ||| S:109 E:115 ||| JJ
cause  ||| S:115 E:121 ||| NN
of  ||| S:121 E:124 ||| IN
morbidity  ||| S:124 E:134 ||| NN
in  ||| S:134 E:137 ||| IN
hospitals  ||| S:137 E:147 ||| NNS
worldwide ||| S:147 E:156 ||| VBD
.  ||| S:156 E:158 ||| .
Urethral  ||| S:158 E:167 ||| NNP
catheters  ||| S:167 E:177 ||| VBD
coated  ||| S:177 E:184 ||| VBN
with  ||| S:184 E:189 ||| IN
antimicrobial  ||| S:189 E:203 ||| JJ
substances  ||| S:203 E:214 ||| NNS
such  ||| S:214 E:219 ||| JJ
as  ||| S:219 E:222 ||| IN
silver  ||| S:222 E:229 ||| JJ
alloy  ||| S:229 E:235 ||| NN
and  ||| S:235 E:239 ||| CC
nitrofurazone  ||| S:239 E:253 ||| NNS
were  ||| S:253 E:258 ||| VBD
introduced  ||| S:258 E:269 ||| VBN
to  ||| S:269 E:272 ||| TO
reduce  ||| S:272 E:279 ||| VB
CAUTI ||| S:279 E:284 ||| NNP
.  ||| S:284 E:286 ||| .
A  ||| S:286 E:288 ||| DT
previous  ||| S:288 E:297 ||| JJ
Cochrane  ||| S:297 E:306 ||| JJ
review  ||| S:306 E:313 ||| NN
reported  ||| S:313 E:322 ||| VBD
that  ||| S:322 E:327 ||| DT
antimicrobial-coated  ||| S:327 E:348 ||| JJ
or  ||| S:348 E:351 ||| CC
impregnated  ||| S:351 E:363 ||| JJ
catheters  ||| S:363 E:373 ||| NNS
may  ||| S:373 E:377 ||| MD
reduce  ||| S:377 E:384 ||| VB
the  ||| S:384 E:388 ||| DT
number  ||| S:388 E:395 ||| NN
of  ||| S:395 E:398 ||| IN
asymptomatic  ||| S:398 E:411 ||| JJ
bacteriuria  ||| S:411 E:423 ||| JJ
present  ||| S:423 E:431 ||| JJ
but  ||| S:431 E:435 ||| CC
it  ||| S:435 E:438 ||| PRP
was  ||| S:438 E:442 ||| VBD
uncertain  ||| S:442 E:452 ||| JJ
whether  ||| S:452 E:460 ||| IN
they  ||| S:460 E:465 ||| PRP
reduced  ||| S:465 E:473 ||| VBD
CAUTI ||| S:473 E:478 ||| NNP
.  ||| S:478 E:480 ||| .
The  ||| S:480 E:484 ||| DT
Catheter  ||| S:484 E:493 ||| NNP
Trial  ||| S:493 E:499 ||| NNP
compared  ||| S:499 E:508 ||| VBD
these  ||| S:508 E:514 ||| DT
and  ||| S:514 E:518 ||| CC
standard  ||| S:518 E:527 ||| JJ
catheters  ||| S:527 E:537 ||| NNS
for  ||| S:537 E:541 ||| IN
short-term  ||| S:541 E:552 ||| JJ
use  ||| S:552 E:556 ||| NN
in  ||| S:556 E:559 ||| IN
NHS  ||| S:559 E:563 ||| NNP
hospitals ||| S:563 E:572 ||| NNS
.  ||| S:572 E:574 ||| .
Results  ||| S:574 E:582 ||| NNS
showed  ||| S:582 E:589 ||| VBD
silver  ||| S:589 E:596 ||| JJ
alloy-coated  ||| S:596 E:609 ||| JJ
catheters  ||| S:609 E:619 ||| NNS
did  ||| S:619 E:623 ||| VBD
not  ||| S:623 E:627 ||| RB
reduce  ||| S:627 E:634 ||| VB
symptomatic  ||| S:634 E:646 ||| JJ
CAUTI  ||| S:646 E:652 ||| NNS
compared  ||| S:652 E:661 ||| VBN
with  ||| S:661 E:666 ||| IN
standard  ||| S:666 E:675 ||| JJ
catheters ||| S:675 E:684 ||| NNS
;  ||| S:684 E:686 ||| :
nitrofurazone-impregnated  ||| S:686 E:712 ||| JJ
catheters  ||| S:712 E:722 ||| NNS
had  ||| S:722 E:726 ||| VBD
borderline  ||| S:726 E:737 ||| JJ
clinical  ||| S:737 E:746 ||| JJ
benefit  ||| S:746 E:754 ||| NN
in  ||| S:754 E:757 ||| IN
reducing  ||| S:757 E:766 ||| VBG
symptomatic  ||| S:766 E:778 ||| JJ
CAUTI ||| S:778 E:783 ||| NNP
.  ||| S:783 E:785 ||| .
The  ||| S:785 E:789 ||| DT
findings  ||| S:789 E:798 ||| NNS
do  ||| S:798 E:801 ||| VBP
not  ||| S:801 E:805 ||| RB
support  ||| S:805 E:813 ||| VB
the  ||| S:813 E:817 ||| DT
routine  ||| S:817 E:825 ||| JJ
use  ||| S:825 E:829 ||| NN
of  ||| S:829 E:832 ||| IN
antimicrobial-coated  ||| S:832 E:853 ||| JJ
or  ||| S:853 E:856 ||| CC
impregnated  ||| S:856 E:868 ||| JJ
catheters  ||| S:868 E:878 ||| NNS
for  ||| S:878 E:882 ||| IN
patients  ||| S:882 E:891 ||| NNS
in  ||| S:891 E:894 ||| IN
hospital  ||| S:894 E:903 ||| NN
who  ||| S:903 E:907 ||| WP
need  ||| S:907 E:912 ||| VBP
short-term  ||| S:912 E:923 ||| JJ
catheters ||| S:923 E:932 ||| NNS
.  ||| S:932 E:934 ||| .
Instead ||| S:934 E:941 ||| RB
,  ||| S:941 E:943 ||| ,
health  ||| S:943 E:950 ||| NN
professionals  ||| S:950 E:964 ||| NNS
should  ||| S:964 E:971 ||| MD
focus  ||| S:971 E:977 ||| VB
on  ||| S:977 E:980 ||| IN
simple  ||| S:980 E:987 ||| JJ
preventive  ||| S:987 E:998 ||| JJ
strategies  ||| S:998 E:1009 ||| NNS
and  ||| S:1009 E:1013 ||| CC
reducing  ||| S:1013 E:1022 ||| VBG
the  ||| S:1022 E:1026 ||| DT
need  ||| S:1026 E:1031 ||| NN
for  ||| S:1031 E:1035 ||| IN
catheterisation ||| S:1035 E:1050 ||| NN
.  ||| S:1050 E:1052 ||| .
